Kalaris Therapeutics, Inc. Price/Book Ratio
The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.
- Kalaris Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 1.68, a 81.63% increase year-over-year.
- Kalaris Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 1.95.
- Kalaris Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 2.44.
- Kalaris Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 2.6.
- Kalaris Therapeutics, Inc. price/book ratio for fiscal 2026 was 1.68.
- Kalaris Therapeutics, Inc. price/book ratio for fiscal 2025 was 2.44.
- Available history
- 2025-06-30 to 2026-06-30
- Data captured
Historical Price/Book Ratio
Annual Price/Book Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |